The objective of the study is to retrospectively collect the data on patients who underwent pelvic organ prolapse treatment using a non-ablative Er:YAG laser with SMOOTH mode and to conduct an objective evaluation of safety and efficacy of Er:YAG laser treatment. In a group of patients that have concomitant stress urinary incontinence symptoms, the effectiveness of the treatments on these symptoms will be evaluated as well.
Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) affect many women and can dramatically decrease their quality of life. Most of the patients diagnosed with stress urinary incontinence also have a degree of pelvic organ prolapse and vice-versa. One of the more promising new approaches in treating disorders connected to pelvic floor dysfunction has been the introduction of vaginal erbium laser treatment for pelvic organ prolapse. The primary aim of the present retrospective study was toassess the effectiveness of vaginal erbium laser with SMOOTH mode for the treatment of patients with pelvic organ prolapse and co-existing stress urinary incontinence, if present.
Study Type
OBSERVATIONAL
Enrollment
41
Non-ablative SMOOTH mode intravaginal Er:YAG teratment for pelvic organ prolapse
Poliklinika Novakov i sar.
Novi Sad, Serbia
Cystocele stage
Assesment of POP grade using Baden-Walker scale
Time frame: Before and at all follow ups (up to 3 months after last treatment)
Severity of stress urinary incontinence
assessment of SUI severity using ICIQ-UI questionnaire
Time frame: Before and at all follow ups (up to 3 months after last treatment)
Assesment of safety
Assesment of adverse effects
Time frame: Before and at all follow ups (up to 3 months after last treatment)
Patient satisfaction
Assesment of patient satisfaction using 0-10 VAS scale
Time frame: Before and at all follow ups (up to 3 months after last treatment)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.